TIKeasy TAblet satisfaCtion (TikTac)

NCT ID: NCT04091152

Last Updated: 2019-10-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-09-19

Study Completion Date

2020-09-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In the last ten years, gerontechnology is becoming an increasing topic in geriatric medicine. Nevertheless, there are still few studies assessing the usability of technologies in old patients, especially when they are hospitalized. Moreover, it has been shown that new technologies could be a source of ageism, thence the importance of involving the old people in the development of these technologies.

Tik easy is a subsidiary of La Poste Company. Tik easy as designed a new tablet PC for old people. Research tends to show that the use of tablet PC can promote health and well-aging, and delay cognitive decline. In this study, we want to give a free access to "Ardoiz", the tablet PC designed by Tik easy, for old patients hospitalized in a geriatric acute care unit. The "Ardoiz" tablet PC allows to:

* Maintain the family and social bond (send and receive messages, share photos and videos, call remotely between the patient and his family)
* Discovering the Internet at his own pace (browse the Internet with daily updated contents such as news, content on cooking, music, etc.).
* Prevent cognitive aging (stimulate cognitive abilities with the DYNSEO games).
* Facilitate online administrative procedures.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The "Ardoiz" tablet PC will be given to old patients hospitalized in the acute care geriatric unit of the university hospital of Angers. Patients and their relatives will have a free access to "Ardoiz" during their hospitalisation. The maximum duration of use will be 9 days. After the using period, a survey will be proposed to the patients and their relatives. This survey include questions concerning usability (using the validated SUS questionnaire), ergonomics (using non validated specific questionnaire with closed questions oriented on "Ardoiz" device), satisfaction (general and specific questions using non validated questionnaire with forced choice Likert scale in 4 points and closed questions). After recruiting all expected patients and relatives; the survey will also be submitted to the professional caregivers of the unit.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Old Age; Debility Satisfaction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

old patients

Patient will freely use "Ardoiz" during their hospitalisation for a maximum of 9 days.

After this use, a survey concerning the usability of "Ardoiz" will be administered to the patient, before their discharge from hospital.

usability assessment

Intervention Type OTHER

Usability of "ardoiz" will be assesse using a validated usability questionnary

relatives / unformal caregivers

Unformal caregivers will freely use "Ardoiz" during the hospitalization of their relatives and a maximum of 9 days.

After this use, a survey concerning the usability of "Ardoiz" will be administered to the unformal caregivers, before the discharge of their hospitalized relatives from hospital.

usability assessment

Intervention Type OTHER

Usability of "ardoiz" will be assesse using a validated usability questionnary

profesionnal caregivers

After the inclusion of all expected patients and relatives, a survey concerning the usability of "Ardoiz" will be administered to professional caregivers.

usability assessment

Intervention Type OTHER

Usability of "ardoiz" will be assesse using a validated usability questionnary

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

usability assessment

Usability of "ardoiz" will be assesse using a validated usability questionnary

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients :

* Aged 65 years old and over
* To be hospitalised in geriatric medicine department of Angers University Hospital
* Caregivers:

* Family members or relatives
* Aged 18 years old and over
* Healthcare team :

* geriatric medicine department's staff of Angers University Hospital
* Aged 18 years old and over

Exclusion Criteria

* Patients :

* Existence of a delirium revealed by the Confusion Assessment Method
* To be under legal protection
* Refusal of participating
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Angers

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cedric Annweiler, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Angers University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Angers University Hospital

Angers, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Cedric Annweiler, MD, PhD

Role: CONTACT

0241354725 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Cédric ANNWEILER, MD, PhD

Role: primary

+33 2 41 35 47 25

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019/41

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.